SVA logo

Sinovac Biotech Ltd. (SVA)

Profile

Full Name

Sinovac Biotech Ltd.

Ticker

NASDAQ: SVA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

China

IPO

September 26, 2003

Indexes

Not included

Website

http://www.sinovacbio.com

Employees

1959

Key Details

Price

$6.47(0.00%)

Market cap

$464.94M(Small cap)

Last Dividend

$55.00

TTM Dividend yield

850.08%

Annual revenue

$448.27M(-69.97% YoY)

Annual EPS

-$1.06(-206.00% YoY)

PE ratio

-

Next earnings date

Jul 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.47
    SVA price is $6.47

    30-Day Relative Volume

    -
    SVA 30-day relative volume value is unknown

    Price Performance

    Price Most recent change

    0%
    SVA price has remained unchanged on Jul 25, 2025

    Price YTD change

    0%
    SVA price has remained unchanged since January 1st

    Price 1-year change

    0%
    SVA price has remained unchanged year-on-year

    Price 3-year change

    0%
    SVA price has remained unchanged over the past 3 years

    Price Range

    Price All-time high

    $12.50
    SVA price is currently -48.24% below its historical high of $12.50

    Price 3-year low

    $6.47
    SVA price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $464.94M
    SVA market capitalization is $464.94 million

    Market cap 3-year change

    -27.78%
    SVA market capitalization is down -27.78% over the past 3 years

    Market cap All-time high

    $643.78M
    SVA market capitalization is currently -27.78% below its historical high of $643.78 million

    Market cap sector rank

    64.55%
    SVA market capitalization is higher than 64.55% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    SVA shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    -27.78%
    SVA shares outstanding is down -27.78% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.00
    SVA beta is 0.00

    200-day SMA

    $6.47
    SVA price is currently equal to its 200-day simple moving average

    50-day SMA

    $6.47
    SVA price is currently equal to its 50-day simple moving average

    RSI

    50.00
    SVA 14-day relative strength index is 50.00

    Volume

    -
    SVA 30-day relative volume value is unknown

    ATR

    $0.00
    SVA average true range is $0.00

    10-day Historical Volatility

    0.00%
    SVA 10-day historical volatility is 0.00%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $55.00
    SVA last dividend was $55.00 per share, with an ex-dividend date of July 8, 2025

    Next Dividend

    -
    SVA next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    SVA annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    SVA annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    SVA annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    SVA annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    SVA annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    SVA annual dividend yield is unknown

    Other

    Payout ratio

    -328.35%
    SVA annual payout ratio is -328.35%

    Dividends paid

    $328.08M
    SVA annual dividends paid is $328.08 million

    Free cash flow

    -$41.69M
    SVA annual free cash flow is -$41.69 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $448.27M
    SVA annual revenue is $448.27 million

    Revenue Analysts estimate

    -
    SVA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -69.97%
    SVA annual revenue is down -69.97% year-on-year

    Revenue Sector rank

    72.8%
    SVA annual revenue is higher than 72.8% of companies in Healthcare sector

    EPS

    EPS

    -$1.06
    SVA annual earnings per share is -$1.06

    EPS Analysts estimate

    -$0.11
    SVA annual earnings per share is currently +863.64% higher than the consensus analysts' forecast

    EPS 1-year change

    -206%
    SVA annual earnings per share is down -206% year-on-year

    EPS Sector rank

    54.44%
    SVA annual earnings per share is higher than 54.44% of companies in Healthcare sector

    Profit

    Gross profit

    $266.75M
    SVA annual gross profit is $266.75 million

    Gross margin

    59.51%
    SVA annual gross profit margin is 59.51%

    Operating profit

    -$524.30M
    SVA annual operating income is -$524.30 million

    Operating margin

    -116.96%
    SVA annual operating profit margin is -116.96%

    Net income

    -$99.92M
    SVA annual net profit is -$99.92 million

    Net margin

    -22.29%
    SVA annual net profit margin is -22.29%

    Expenses

    Total expenses

    $972.57M
    SVA annual total expenses is $972.57 million

    Operating expenses

    $791.05M
    SVA annual total operating expenses is $791.05 million

    Cost of goods sold

    $181.52M
    SVA annual cost of goods sold is $181.52 million

    Selling, general & administrative expenses

    $466.32M
    SVA annual SGA is $466.32 million

    Depreciation and amortization

    $144.75M
    SVA annual depreciation & amortization is $144.75 million

    Interest expense

    $2.26M
    SVA annual interest expense is $2.26 million

    Income tax

    $105.32M
    SVA annual income tax is $105.32 million

    EBIT & EBITDA

    EBIT

    -$150.77M
    SVA annual earnings before interest & taxes is -$150.77 million

    EBITDA

    -$6.03M
    SVA annual EBITDA is -$6.03 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $13.66B
    SVA annual total assets is $13.66 billion

    Non current assets

    $1.83B
    SVA annual long term assets is $1.83 billion

    Current assets

    $11.83B
    SVA annual total current assets is $11.83 billion

    Cash and cash equivalents

    $1.27B
    SVA annual cash & cash equivalents is $1.27 billion

    Accounts receivable

    $426.01M
    SVA annual accounts receivable is $426.01 million

    Inventory

    $139.87M
    SVA annual inventory is $139.87 million

    Liabilities

    Total liabilities

    $1.64B
    SVA annual total liabilities is $1.64 billion

    Long term liabilities

    $487.30M
    SVA annual total long term liabilities is $487.30 million

    Current liabilities

    $1.15B
    SVA annual total current liabilities is $1.15 billion

    Accounts payable

    $17.29M
    SVA annual accounts payable is $17.29 million

    Debt

    Total debt

    $298.98M
    SVA annual total debt is $298.98 million

    Total debt 1-year change

    +300.39%
    SVA annual total debt is up +300.39% year-on-year

    Long term debt

    $217.09M
    SVA annual long term debt is $217.09 million

    Short term debt

    $81.89M
    SVA annual short term debt is $81.89 million

    Equity & Capital

    Shareholders equity

    $8.71B
    SVA annual stockholders equity is $8.71 billion

    Book value

    $8.71B
    SVA annual book value is $8.71 billion

    Retained earnings

    $7.12B
    SVA annual retained earnings is $7.12 billion

    Working capital

    $10.68B
    SVA annual working capital is $10.68 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $104.00M
    SVA annual cash flow from operations is $104.00 million

    Cash from operations 1-year change

    +113.49%
    SVA annual cash flow from operations is up +113.49% year-on-year

    Cash from investing

    -$2.92B
    SVA annual cash flow from investing activities is -$2.92 billion

    Cash from investing 1-year change

    +49.24%
    SVA annual cash flow from investing activities is up +49.24% year-on-year

    Cash from financing

    -$76.06M
    SVA annual cash flow from financing activities is -$76.06 million

    Cash from financing 1-year change

    +68.49%
    SVA annual cash flow from financing activities is up +68.49% year-on-year

    CAPEX

    CAPEX

    $145.69M
    SVA annual capital expenditures is $145.69 million

    CAPEX 1-year change

    -63.88%
    SVA annual capital expenditures is down -63.88% year-on-year

    Free Cash Flow

    Free cash flow

    -$41.69M
    SVA annual free cash flow is -$41.69 million

    Free cash flow 1-year change

    +96.45%
    SVA annual free cash flow is up +96.45% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    59.51%
    SVA annual gross profit margin is 59.51%

    Operating margin

    -116.96%
    SVA annual operating profit margin is -116.96%

    Net margin

    -22.29%
    SVA annual net profit margin is -22.29%

    ROA & ROE

    ROA

    -0.72%
    SVA annual return on assets is -0.72%

    ROE

    -0.81%
    SVA annual return on equity is -0.81%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SVA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SVA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.05
    SVA price to book ratio is 0.05

    PB ratio Sector rank

    17.12%
    SVA price to book ratio is higher than 17.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    SVA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    SVA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$282.90M
    SVA enterprise value is -$282.90 million

    Enterprise value Sector rank

    0%
    SVA enterprise value is higher than 0% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    SVA EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    SVA EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.31
    SVA annual current ratio is 10.31

    Quick ratio

    10.18
    SVA annual quick ratio is 10.18

    Leverage

    Debt to equity

    0.03
    SVA annual debt to equity ratio is 0.03

    Interest coverage ratio

    -66.71
    SVA annual interest coverage ratio is -66.71

    Risk & Stability

    Piotroski F-Score

    -
    SVA piotroski f-score value is unknown

    Altman Z-Score

    1.84
    SVA altman z-score is 1.84

    Analyst ratings

    Recent major analysts updates

    Mar 20, 14 Morgan Stanley
    Overweight
    Nov 13, 13 Aegis Capital
    Buy
    Aug 15, 13 Aegis Capital
    Buy
    May 15, 13 Morgan Stanley
    Equal-Weight
    Mar 14, 13 Aegis Capital
    Hold
    Dec 12, 12 Aegis Capital
    Hold

    Institutional Ownership

    Screeners with SVA included

    Highest dividend in sector
    Chinese stocks
    Most recommended stocks
    Earnings today
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Stocks above analysts price target
    High-Yield Dividend Stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Sinovac Biotech Ltd.?
    • Does Sinovac Biotech Ltd. pay dividends?
    • What sector is Sinovac Biotech Ltd. in?
    • What industry is Sinovac Biotech Ltd. in?
    • What country is Sinovac Biotech Ltd. based in?
    • When did Sinovac Biotech Ltd. go public?
    • Is Sinovac Biotech Ltd. in the S&P 500?
    • Is Sinovac Biotech Ltd. in the NASDAQ 100?
    • Is Sinovac Biotech Ltd. in the Dow Jones?
    • When was Sinovac Biotech Ltd.'s last earnings report?
    • When does Sinovac Biotech Ltd. report earnings?

    What is the ticker symbol for Sinovac Biotech Ltd.?

    The ticker symbol for Sinovac Biotech Ltd. is NASDAQ:SVA

    Does Sinovac Biotech Ltd. pay dividends?

    Yes, Sinovac Biotech Ltd. pays dividends. The last payment was $55.00, with an ex-dividend date on July 8, 2025

    What sector is Sinovac Biotech Ltd. in?

    Sinovac Biotech Ltd. is in the Healthcare sector

    What industry is Sinovac Biotech Ltd. in?

    Sinovac Biotech Ltd. is in the Biotechnology industry

    What country is Sinovac Biotech Ltd. based in?

    Sinovac Biotech Ltd. is headquartered in China

    When did Sinovac Biotech Ltd. go public?

    Sinovac Biotech Ltd.'s initial public offering (IPO) was on September 26, 2003

    Is Sinovac Biotech Ltd. in the S&P 500?

    No, Sinovac Biotech Ltd. is not included in the S&P 500 index

    Is Sinovac Biotech Ltd. in the NASDAQ 100?

    No, Sinovac Biotech Ltd. is not included in the NASDAQ 100 index

    Is Sinovac Biotech Ltd. in the Dow Jones?

    No, Sinovac Biotech Ltd. is not included in the Dow Jones index

    When was Sinovac Biotech Ltd.'s last earnings report?

    Sinovac Biotech Ltd.'s most recent earnings report was on April 28, 2025

    When does Sinovac Biotech Ltd. report earnings?

    The next expected earnings date for Sinovac Biotech Ltd. is July 28, 2025
    On this page